DiscoverKDIGO Conversations in NephrologyEpisode 26: Burden and Pathophysiology of APOL1 Kidney Disease
Episode 26: Burden and Pathophysiology of APOL1 Kidney Disease

Episode 26: Burden and Pathophysiology of APOL1 Kidney Disease

Update: 2025-10-28
Share

Description

This is the first episode of a three-part KDIGO Conversations in Nephrology series on APOL1 kidney disease. Host Kirk Campbell, MD (University of Pennsylvania, United States), speaks with Bessie Young, MD (University of Washington, United States) about the discovery, burden, and biology of APOL1 kidney disease. Their discussion explores how APOL1 variants contribute to increased kidney disease risk in people of African ancestry, recent findings on protective variants, and ongoing research toward targeted therapies.

Learn more and access resources from the KDIGO Controversies Conference on APOL1 Kidney Disease: https://kdigo.org/conferences/apol1-kidney-disease/


This podcast was supported by Vertex Pharmaceuticals.

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 26: Burden and Pathophysiology of APOL1 Kidney Disease

Episode 26: Burden and Pathophysiology of APOL1 Kidney Disease

KDIGO Communications